|
| 1952 |
|
•Mr. Ming-Ning Wang founded the China Chemical & Pharmaceutical Co., Ltd. (CCPC) and established a plant in Shulin, Taipei County, Taiwan, ROC.
|
| 1962 |
|
•The company went public after approval by the Ministry of Economic Affairs.
|
| 1964 |
|
•Established China Chemical Synthesis Industrial Co., Ltd. to manufacture finechemicals and bulk materials.
|
| 1973 |
|
•Introduced animal products to complement the existing pesticide business.
|
|
1978
|
|
•First to implement GMP in Taiwan; inaugurated a new GMP-compliant plant.
|
|
1984
|
|
•CCPC Shulin factory garnered government certification as a GMP factory.
|
|
1986
|
|
•CCPC contracted with IBM in order to computerize the entire organization.
|
|
1989
|
|
•In memory of the late CCPC founder Ming-Ning Wang who passed away in 1988, the Ming-Ning Wang Memorial Foundation was established to fund medical research.
|
|
1990
|
|
•The Shulin Research Center Building along with the Tainan Plant I and dormitory were commissioned into use.
|
|
1991
|
|
•Construction began on the Taichung Branch Building as well as the Taichung Consumer Products Plant.
|
|
1992
|
|
•Established the Consumer Product Division and Animal Health Division for the manufacturing and marketing of related products.
|
| 1993 |
|
•Invested in Suzhou ChungHwa Pharmaceutical & Chemical Industrial Co., Ltd.(SCCPC) in Mainland China through an overseas holding company; TaichungConsumer Products Plant inaugurated and commissioned.
|
|
1994
|
|
•Construction of SCCPC was completed and production started.
|
|
1996
|
|
•The Sinfong Plant, the first cGMP pharmaceutical plant in Taiwan, was commissioned.
|
|
1998
|
|
•SCCPC received GMP certification in Mainland China. CCPC received the National Medical & Pharmaceutical Award.
|
|
1999
|
|
•CCPC and SynZyme Technology, LLC. signed a joint-venture agreement. The platform technology will be used for treating cardiovascular diseases, such as stroke, multiple organ failure, ischemia reperfusion damage, etc. SCCPC & CCPC will develop new drugs and perform clinical trials in China and Taiwan. CCPC received the National Bio & Medical Care Quality Award.
|
|
2000
|
|
•CCPC invested in NeuroLogic Inc. (NLI), a biotech company developing Alzheimer’s disease diagnostics and new drugs for dementia. CCPC is granted manufacturing and marketing rights for Asia.
|
|
2001
|
|
•The Sinfong and Taichung Plants were the first groups to pass the first phase of cGMP certification.
|
|
2002
|
|
•SCCPC passed the ISO 14001 certification in Mainland China. The Taichung Plant passed the second and third phase of cGMP certification by the Department of Health, Executive Yuan, ROC (Taiwan).
|
|
2004
|
|
•In order to separate manufacturing and marketing, CCPC established ChungHwa Yuming Health Care Co. in Jhongjheng District, Taipei. The Shulin Research Center also moves to the Sinfong Plant in Hsinchu County.
|
|
2005
|
|
•CCPC bought and merged the Tainan Plant of Japan Sankyo Co., Ltd. then established the CCPC Tainan Plant II in Guantian Township, Tainan County, Taiwan.
|
|
2006
|
|
•In order to provide the best quality of service to customers, the Customer Products Division became ChungHwa Biochemical Technology Corp. in Neihu District, Taipei.
|
|
|
|
|
|
|
